Ausgabe 2/2016
Inhalt (9 Artikel)
Epidemiological Trends in NASH as a Cause for Liver Transplant
Way Siow, David van der Poorten, Jacob George
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Lisa B. VanWagner, Mary E. Rinella
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease
Saumya Jayakumar, Stephen A. Harrison, Rohit Loomba
The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us?
Leon A. Adams, Mark Morrison
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders
Anna Simona Sasdelli, Lucia Brodosi, Giulio Marchesini
Nonalcoholic Steatohepatitis and Liver Transplantation
Zobair M. Younossi, Linda Henry
Nonalcoholic Fatty Liver Disease: Prognosis and Progression of Disease
Zachary H. Henry, Stephen H. Caldwell, Curtis K. Argo
Future Treatments of NASH
Brent A. Neuschwander-Tetri
Lean NAFLD: an Underrecognized Outlier
Julia Wattacheril, Arun J. Sanyal